China · Who invested in Clover Biopharmaceutical?
Clover Biopharmaceutical's investors include Delos Capital, Lapam Capital, Beijing Zhongguancun VC, Betta Capital and Jinlong Group, and 1 more on record. Delos Capital led its latest round.
China · Series B startup
Who invested in Clover Biopharmaceutical
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$43Mraised across 1 round since 2019, from 1 source
- Latest round
- Series B, $43MNov 2019
- Led by
- Delos Capital and Lapam Capital
- Investors
- 6 (2 led)
The rounds
- Nov 2019Series B$43M
Delos CapitalLead- Lapam CapitalLead
- Beijing Zhongguancun VC
- Betta Capital
- Jinlong Group
- Sichuan Health Care Industry Fund
Reported by FinSMEs
Everyone who backed them
Lapam CapitalInvestment firm1round, led 1
Beijing Zhongguancun VCno record of our own yet1round
Betta Capitalno record of our own yet1round
Jinlong Groupno record of our own yet1round
Sichuan Health Care Industry Fundno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Clover Biopharmaceutical
How much has Clover Biopharmaceutical raised?
Clover Biopharmaceutical has raised $43M across 1 round since 2019.
When did Clover Biopharmaceutical last raise?
Clover Biopharmaceutical's most recent round was a Series B of $43M in Nov 2019, led by Delos Capital.
What was Clover Biopharmaceutical's biggest round?
Its most recent round, $43M in Nov 2019, is also its largest on record.
Who backed Clover Biopharmaceutical first?
Clover Biopharmaceutical's first round on record, in Nov 2019, was backed by Delos Capital, Lapam Capital and Beijing Zhongguancun VC and 3 others.
What stage is Clover Biopharmaceutical at?
Clover Biopharmaceutical's latest named round is a Series B, in Nov 2019.
Where is Clover Biopharmaceutical based?
Clover Biopharmaceutical is based in China.
Who led Clover Biopharmaceutical's rounds?
Delos Capital led the Series B in 2019.
Companies like Clover Biopharmaceutical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.